Dupixent 200 MG/1.14 ML syring 1.14ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3N7D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,017
Award facts
- Contract value 100% obligated
- $14,017.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,017.45 to AmerisourceBergen Drug Corp for Dupixent 200 mg/1.14 mL syringes on December 2, 2025, with an ultimate completion date of December 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis, eosinophilic asthma, and chronic rhinosinusitis with nasal polyps, making this a critical pharmaceutical supply for military and veteran healthcare systems.
This delivery order is a child contract issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal contract portfolio with DLA focused on meeting diverse medical supply needs across multiple therapeutic domains for the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F3N7D?
SPE2DR26F3N7D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F3N7D worth?
The government has obligated $14,017 on SPE2DR26F3N7D.
Is contract SPE2DR26F3N7D an order under another contract?
Yes. SPE2DR26F3N7D is a delivery order under SPE2DR25D3008, an indefinite delivery contract.
Was contract SPE2DR26F3N7D competed?
The extent of competition for SPE2DR26F3N7D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award